Endocrine Abstracts

Objective: To evaluate cost-effectiveness of GH treatment (Genotropin) in adult patients with GHD by comparing health status and costs in patients who received GH treatment with those who did not.Methods: Direct costs included health care costs related to morbidity (stroke, cardiovascular events) and GH costs. Indirect costs were determined by sick-leave and mortality. A model (Markov-type) was constructed to simulate differences in morbidity and mortali...